We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

How to spend it

4 August 2021 By Aimee Donnellan

Diagnostic groups like Roche and Abbott Laboratories were the big winners of the pandemic, with their market values swelling by nearly $230 bln. The advent of vaccines means demand for their services will wane. Dealmaking could be a fix but only if companies can avoid overpaying.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)